Reflex Sympathetic Dystrophy
7
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
14.3%
1 terminated out of 7 trials
83.3%
-3.2% vs benchmark
14%
1 trials in Phase 3/4
80%
4 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Audio-Visual Relaxation Technology for Pediatric Amplified Musculoskeletal Pain Syndrome
Efficacy and Safety of a Learning Program of Self- Rehabilitation Exercises by Mirror Therapy
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
Effects of Vaporized Marijuana on Neuropathic Pain
Investigation of the Efficacy of tDCS in the Treatment of Complex Regional Pain Syndrome (CRPS) Type 1
Effects of Pennsaid on Clinical Neuropathic Pain
Near-infrared Spectroscopic Measurement in Complex Regional Pain Syndrome